Entrada Therapeutics (TRDA) files $400M mixed shelf
Tweet
Share
E-mailGet Alerts TRDA Hot Sheet
Join SI Premium – FREE
Entrada Therapeutics (NASDAQ: TRDA) has filed $400,000,000 mixed shelf of:
Common Stock
Preferred Stock
Debt Securities
Warrants
Units
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nscale targets up to $3B in US IPO as soon as September - Bloomberg
- Aptevo Therapeutics files prospectus for resale of 6.4M shares
- Imax extends Chief Legal Officer Lister's contract through 2029
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
